These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34589084)

  • 41. Conjugation of toll-like receptor-7 agonist to gastric cancer antigen MG7-Ag exerts antitumor effects.
    Wang XD; Gao NN; Diao YW; Liu Y; Gao D; Li W; Wan YY; Zhong JJ; Jin GY
    World J Gastroenterol; 2015 Jul; 21(26):8052-60. PubMed ID: 26185376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
    Vieira JF; Peixoto AP; Murta EFC; Michelin MA
    Anticancer Res; 2021 Jul; 41(7):3419-3427. PubMed ID: 34230137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour.
    Jeong SH; Yang MJ; Choi S; Kim J; Koh GY
    Nat Commun; 2021 Jul; 12(1):4405. PubMed ID: 34285232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancing immunotherapy of STING agonist for lymphoma in preclinical models.
    Sallets A; Robinson S; Kardosh A; Levy R
    Blood Adv; 2018 Sep; 2(17):2230-2241. PubMed ID: 30194137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy.
    Zhan M; Yu X; Zhao W; Peng Y; Peng S; Li J; Lu L
    J Nanobiotechnology; 2022 Jan; 20(1):23. PubMed ID: 34991618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model.
    Kwilas AR; Ardiani A; Dirmeier U; Wottawah C; Schlom J; Hodge JW
    Oncotarget; 2015 Sep; 6(29):28194-210. PubMed ID: 26317648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.
    Singh M; Quispe-Tintaya W; Chandra D; Jahangir A; Venkataswamy MM; Ng TW; Sharma-Kharkwal S; Carreño LJ; Porcelli SA; Gravekamp C
    Br J Cancer; 2014 Nov; 111(10):1945-54. PubMed ID: 25314062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.
    Lu ZD; Chen YF; Shen S; Xu CF; Wang J
    ACS Appl Mater Interfaces; 2021 Jun; 13(25):29424-29438. PubMed ID: 34129318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
    Bryson PD; Han X; Truong N; Wang P
    Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.
    Foote JB; Kok M; Leatherman JM; Armstrong TD; Marcinkowski BC; Ojalvo LS; Kanne DB; Jaffee EM; Dubensky TW; Emens LA
    Cancer Immunol Res; 2017 Jun; 5(6):468-479. PubMed ID: 28483787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.
    Li J; Ren H; Qiu Q; Yang X; Zhang J; Zhang C; Sun B; Lovell JF; Zhang Y
    ACS Nano; 2022 Oct; 16(10):16909-16923. PubMed ID: 36200692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
    Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
    Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Combination of TLR7 agonist T7-ethacrynic acid conjugate with ROR1 has a stronger anti-breast cancer effect].
    Zhang N; Jin G; Jin Z; Liu B; Peng B; Gao N; Hu Y; Tang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):876-80. PubMed ID: 27363264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.
    Ma Z; Li N; Zhang B; Hui Y; Zhang Y; Lu P; Pi J; Liu Z
    J Nanobiotechnology; 2020 Sep; 18(1):123. PubMed ID: 32887626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
    El-Ashmawy NE; El-Zamarany EA; Salem ML; Khedr EG; Ibrahim AO
    Mol Immunol; 2019 Jul; 111():106-117. PubMed ID: 31051312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination.
    Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z
    ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.